BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Liver cancer AND SDHD, PGL1, 6392, ENSG00000204370, PGL, SDH4, CBT1, O14521 AND Treatment
14 results:

  • 1. Emerging treatments for Advanced/Metastatic Pheochromocytoma and Paraganglioma.
    Ilanchezhian M; Jha A; Pacak K; Del Rivero J
    Curr Treat Options Oncol; 2020 Aug; 21(11):85. PubMed ID: 32862332
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Multiple metabolic parameters and visual assessment of
    Ren Y; Liu J; Wang L; Luo Y; Ding X; Shi A; Liu J
    Abdom Radiol (NY); 2020 Nov; 45(11):3569-3580. PubMed ID: 32274551
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Temozolomide treatment of a malignant pheochromocytoma and an unresectable MAX-related paraganglioma.
    Ferrara AM; Lombardi G; Pambuku A; Meringolo D; Bertorelle R; Nardin M; Schiavi F; Iacobone M; Opocher G; Zagonel V; Zovato S
    Anticancer Drugs; 2018 Jan; 29(1):102-105. PubMed ID: 29099418
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Phase II trial of pazopanib in advanced/progressive malignant pheochromocytoma and paraganglioma.
    Jasim S; Suman VJ; Jimenez C; Harris P; Sideras K; Burton JK; Worden FP; Auchus RJ; Bible KC
    Endocrine; 2017 Aug; 57(2):220-225. PubMed ID: 28685225
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Polymorphisms in Genes of Tricarboxylic Acid Cycle Key Enzymes Are Associated with Early Recurrence of Hepatocellular Carcinoma.
    Wan S; Wu Y; Zhou X; Chen Y; An J; Yu X; Zhang H; Yang H; Xing J
    PLoS One; 2015; 10(4):e0124471. PubMed ID: 25894340
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Genotype and tumor locus determine expression profile of pseudohypoxic pheochromocytomas and paragangliomas.
    Shankavaram U; Fliedner SM; Elkahloun AG; Barb JJ; Munson PJ; Huynh TT; Matro JC; Turkova H; Linehan WM; Timmers HJ; Tischler AS; Powers JF; de Krijger R; Baysal BE; Takacova M; Pastorekova S; Gius D; Lehnert H; Camphausen K; Pacak K
    Neoplasia; 2013 Apr; 15(4):435-47. PubMed ID: 23555188
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Hepatic dysfunction after radiotherapy for primary gastric lymphoma.
    Tanaka H; Hayashi S; Ohtakara K; Hoshi H
    J Radiat Res; 2013 Jan; 54(1):92-7. PubMed ID: 23283868
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. A pharmacodynamic study of the P-glycoprotein antagonist CBT-1® in combination with paclitaxel in solid tumors.
    Kelly RJ; Robey RW; Chen CC; Draper D; Luchenko V; Barnett D; Oldham RK; Caluag Z; Frye AR; Steinberg SM; Fojo T; Bates SE
    Oncologist; 2012; 17(4):512. PubMed ID: 22416063
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Successful chemotherapy of hepatic metastases in a case of succinate dehydrogenase subunit B-related paraganglioma.
    He J; Makey D; Fojo T; Adams KT; Havekes B; Eisenhofer G; Sullivan P; Lai EW; Pacak K
    Endocrine; 2009 Oct; 36(2):189-93. PubMed ID: 19618298
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. FDG avidity and PET/CT patterns in primary gastric lymphoma.
    Radan L; Fischer D; Bar-Shalom R; Dann EJ; Epelbaum R; Haim N; Gaitini D; Israel O
    Eur J Nucl Med Mol Imaging; 2008 Aug; 35(8):1424-30. PubMed ID: 18418594
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Superiority of fluorodeoxyglucose positron emission tomography to other functional imaging techniques in the evaluation of metastatic SDHB-associated pheochromocytoma and paraganglioma.
    Timmers HJ; Kozupa A; Chen CC; Carrasquillo JA; Ling A; Eisenhofer G; Adams KT; Solis D; Lenders JW; Pacak K
    J Clin Oncol; 2007 Jun; 25(16):2262-9. PubMed ID: 17538171
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Systematic radical gastrectomy and D2 lymphadenectomy in primary gastric B cell lymphoma: impact on diagnosis, classification and long term results. A prospective study.
    Caronna R; Cardi M; Martelli M; Finolezzi E; Natalino F; Mingazzini P; Scozzafava S; Mangioni S; Romeo BG; Tarantino E; Benedetti M; Pittau G; Schiratti M; Chirletti P
    J Chemother; 2004 Nov; 16 Suppl 5():26-9. PubMed ID: 15675472
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Characteristics and application of established luciferase hepatoma cell line that responds to dioxin-like chemicals.
    Zhang ZR; Xu SQ; Sun X; Xu YJ; Cai XK; Liu ZW; Tan XL; Zhou YK; Zhang JY; Yan H
    World J Gastroenterol; 2003 Jul; 9(7):1460-4. PubMed ID: 12854141
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Hepatitis B disease in dialysis and transplant patients. Further epidemiologic and serologic studies.
    Harnett JD; Zeldis JB; Parfrey PS; Kennedy M; Sircar R; Steinmann TI; Guttmann RD
    Transplantation; 1987 Sep; 44(3):369-76. PubMed ID: 2820093
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.